CAT vs MYGN · P/E 48, rev $37.96B vs rev $837.6M
Caterpillar Inc (CAT) versus Myriad Genetics Inc (MYGN) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Myriad Genetics Inc (MYGN) is a diagnostics & research company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported MYGN revenue for 2024-12-31 was $837.6M. Net income was -$127.3M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. MYGN currently screens at market cap $413.7M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. MYGN currently screens at market cap $413.7M.
Not investment advice. Open the CAT and MYGN stock pages for the full models.
Not investment advice.